Académique Documents
Professionnel Documents
Culture Documents
Enzyme-Catalyzed Reactions
Chapter 12
Formylations,
Hydroxymethylations, and
Methylations
Tetrahydrofolate-dependent Enzymes
Transfer of one-carbon units
H2N
H
N
5 6
HN
O
N
H
pKaofacid=4.8
5,6,7,8tetrahydro
pteridine
can be oligomer of up
to 12 Glu residues
N
H
H
C N CHCH2CH2COO
10
pKaofacidis1.25
pamino
benzoicacid
COO
glutamate
12.1
tetrahydrofolate
named as polyglutamate derivatives of
tetrahydrofolate (H4PteGlun) [Pte - pteroate]
pteroate
ring
H2N
HN
O
H
N
5
N
H
12.2
NHR'
10
Folic Acid
(a vitamin for humans)
H2N
HN
N
N
O
N
H
12.3
CNH
CHCH2CH2COO
COO
H
H2N
HN
..
N
R
N
O
NH2
HN
H2N
H O
12.3
dihydrofolate
reductase
H
N
NH2
N
O
NHR'
H
B+
HN
O
NH2
N
NHR'
N+
R
dihydrofolate
H O
..
N
R
NHR'
H2N
H
N
dihydrofolate
reductase
H2N
H
N
NH2
HN
O
N
H
NHR'
N+
R
12.1
Scheme 12.1
Lys
HN+
:NH2
OH
=O PO
3
COO
H
*
SeeScheme
8.39
* H
H
COO
OH
OH
=O PO
3
..
N
H
-cleavage
+N
H
N+
H
12.4
HN+
H2N
COO
=O
OH
3PO
+N
H
=O
OH
3PO
+N
H
pro-S hydrogen
added/removed
(retention of
configuration) H
Lys
HN+
OH
=O PO
3
COO
HN+
*
O CH2
HN+
COO
=O
+B
COO Lys
:NH2
HN+
OH
3PO
+N
H
COO
H
HN+
OH
=O PO
3
+N
H
Scheme 12.2
HN
O
*
O C
B+
H
N
5..
N
H
H2N
HN
10
+B
OH
H2N
H NHR'
B:
H
N
H2N
H
N
HN
+
N
HN
N
O
* CH2 : NHR'
B
12.6
*C
H2
H
H2N
HN
+
NR'
H
:B
N -methylene H4Pte
5
12.5
Scheme 12.3
H2O
O *CH2
NHR'
H
N
H
N
N
H +NR'
O
*C
H2
12.8
12.7
N ,N -methylene H4Pte
5
10
N10-methylene H4Pte
H
N
H2 N
N
O
NR'
H
H *
12.12
:B
H
N5,N10-methenyltetrahydrofolate cyclohydrolase
H
N
N
H
NR'
12.9
H2N
H
N
N -formyl H4Pte
+B
N
*
NR'
H2N
H
N
HN
HN
HN
HO
N+
R
10
..
N
H
NH2
H O
NH2
HN
HN
H2N
H
N
H
12.10
NR'
a
O
H
:B
N
O
B+
O NHR'
12.11
N5-formyl H4Pte
Scheme 12.5
H
N
5 6
HN
N
O
CH3
NHR'
12.13
N5-methyl H4Pte
H
N
H2N
H
HN
HN
N
O
CH2
N
O
NHR'
H
N
CH3
12.14
H2N
N
HN
H
N
N
CH2
NHR'
3H
NHR'
NADPH
+H+
NADP+
FADH
H2N
HN
+
H2N
H
N
N
O HC
2
CH2 NHR'
12.6
FADH
Scheme 12.7
H2N
+
N
HN
H
N
+
NHR'
12.7
H
N
+
N
HN
O
CH3 NHR'
FAD
B
H2N
HN
H
N
N
CH3 NHR'
12.13
NADP+
H2 N
FAD
+
N
HN
D2O
H
N
CH2 NHR'
12.6
Scheme 12.8
H2 N
HN
H2N
HN
H
N
N
O HC
2
+
NHR'
12.7
H
N
N
CH2 NHR'
D
HN
O
H
N
N
H
H
O
=O PO
3
O
HO
..
NH2
HN
H2N
HN
O
NR'
O
H
B
=O
3PO
HN
HO
OH
12.17
12.16
GAR
H
N
H2N
HN
N
H
NR'
O
N H H
H
N
H
12.2
NHR'
H
O
:B
=O PO
3
B:
OH
H
N
HO
HN
OH
12.18
FGAR
Scheme 12.9
NH
O
5
HN
=O
3PO
O
O
CH3
HN
H2N
H
+
N
N
12.19
Scheme 12.10
=O PO
3
N
O
N
HO
HO
H
N
H
reduced
(normally CH2OH)
H2N
H
+
H
N
N
N
N
HO
HO
12.20
N
H
oxidized
HN
O
H2N
+
N
dRP
H
N
3H
HN
O
Scheme 12.11
C3HH2
HN
H2 N
O
R
N
dRP
N
HN
H
N
N
O
N
H
MeN
O
N
Me
12.21
OH
OH
MeN
N
Me
Scheme 12.12
H
OH
H
D
MeN
N
Me
H
OH
OH
MeN
O
N
Me
H
OH
12.22
MeN
N
Me
O
F
MeN
=O
3PO
NH
O
F
N
CH2
HN
=O
3PO
NH
N
S
Cys
C
HO
HO
12.23
Scheme 12.13
12.24
structure identified
by X-ray
Glu
H
N
..
N
HN
O
O
3PO
N
O
H
S
O
B
=O PO
3
HN
N
O
O
CH2
Cys
Scheme 12.14
HO
CH2
H
HN
=O PO
3
N
O
Cys
HO
N
O
NHR
H
S
HN
N
O
H
N
H2N
HN
NR
H
HN
=O
H2C
H
N
H2N
HO
H
S
Cys
NHR
B
Original Proposal
Highly unlikely [1,3]-H shift mechanism for reduction
of the substrate catalyzed by thymidylate synthase
H
N
H2N
HN
=O
3PO
HO
[1,3]-H shift
suprafacial
HN
NHR
12.25
Cys
CH3
=O
3PO
O
O
HO
NHR
HN
B
S
N
O
H
N
CH2
HN
O
H2N
..
N
H
N
H
S
Cys
Scheme 12.15
H2N
HN
O
CH2
H
HN
=O
3PO
:B
N
HO
NHR
HN
H
S
Cys
CH2
..
N
H
Cys
B
O
=O PO
3
Scheme 12.16
HO
H
S
Cys
12.26
O
CH3
HN
=O PO
3
N
O
HO
CH2
HN
O NHR
HO
12.25
H
N
NHR
=O PO
3
HN
N
OO
when F, it
is stable
H2N
H
HN
N
O
H
N
H2N
H
Cys
CH3
HN
=O PO
3
N
O
HO
H
S
Cys
H2N
HN
H
N
N
NHR
MeN
O
N
Me
12.27
NO2
H
OH
CH2 O
MeN
O
N
Me
H
OH
NO2
CH2
MeN
O
OH
N
Me
H
OH
O
CH2OH
MeN
N
Me
H
OH
Scheme 12.17
CH2OH
MeN
O
N
Me
HN
=O
3PO
N
O
HO
O
HN
OH
H
S
Cys
12.26
=O
OH
3PO
N
O
HO
HN
S
H
S
Cys
=O
3PO
S
N
O
O
HO
H
S
12.28
isolated
Scheme 12.18
Cys
OH
H2N
HN
NHR
CH2
HN
=O
3PO
O
O
HO
Cys
CH2
HN
H
=O
12.26
3PO
O
O
HO
12.29
H
S
Cys
=O
3PO
Cys
NHR
SET
H+
CH3
HN
H
S
NHR
CH3
O
HO
HN
HN
H
N
H2N
NHR
SET
HN
N
H
H
N
H2N
HN
N
H
H
N
H2N
=O
3PO
N
O
H
S
Cys
HO
12.30
Scheme 12.19
CH3
HN
=O
3PO
O
O
HO
H
Cys
H
N
HS
HN
N
O
CH3
COO
NHR
Scheme 12.20
NH3+
12.31
H2N
H
N
+
HN
O
N
H
COO
CH3S
NH3+
NHR
12.32
H
N
Na+
CH3
HN
N
O H3C
CH3
CH3
H
N
COO
NH3+
SN 2
N
HN
H
N
CH3
N
O
CH3S
CH3
COO
NH3+
CH3
12.33
increases leaving
group ability
(model for protonated
N5-Me-H4PteGlu)
Scheme 12.21
CONH2
CH3
H2NOC
A
H3C
N B
N
corrin
H3C
Co+
CONH2
H
CH
H2NOC
N
N
3
D
H3C
C
CH3
HN
H3C
H3C
H3C
CONH2
H3C
H
O
ring
HO
O
O
P
H
O
CH2OH
12.34
methylcobalamin
from the methylation of cob(I)alamin by N5-MeH4PteGlu
Met
CH3cobalamin
H4PteGlu
CH3H4PteGlu
HCys
cob(I)alamin
retention of Me
configuration
CH3H4PteGlu
Met
Cleland
notation
H4PteGlu
B
E
cobalamin
Scheme 12.22
CH3cob(I)alamin
cobalamin
Enzyme reaction
pathway
cob(I)alamin
H
N
N
HN
H
N
CH3
N
O H3 C
methylcobalamin
CH3
CH3
12.33
Scheme 12.23
N
HN
H
N
N
O
CH3
CH3
CH3
S-Adenosylmethionine (SAM)-Dependent
Transfer of CH3
Proposed mechanism for the synthesis of S-adenosylmethionine
catalyzed by methionine adenosyltransferase
COO
H3N
O
=O
3P O P O
CH3
O
P
CH2
O
HO
OH
12.35
ATP
Scheme 12.24
A methionine
adenosyltransferase
PPi+Pi
OOC
CH3
S
O
H3N
HO
OH
12.36
SAM
more common methylating agent
H
R
OOC
Scheme 12.25
:B
X
CH3
OOC
O
H3N
HO
OH
12.36
SN2
CH3
O
H3N
HO
OH
12.37
inversion of
stereochemistry
COO
H3 N
D
S
adenosyl
:B
H
T B:
H
H
12.38
indolylpyruvate
Scheme 12.26
D
O
COO
COO
COO
N
H
N
H
N
H
D
O
NHCH3
N
N
H
12.39
indolmycin